Authors: Campbell, T Blasko, J Crawford, ED Forman, J Hanks, G Kuban, D Montie, J Moul, J Pollack, A Raghavan, D Ray, P Roach, M Steinberg, G Stone, N Thompson, I Vogelzang, N Vijayakumar, S

Citation: T. Campbell et al., Clinical staging of prostate cancer: Reproducibility and clarification of issues, INT J CANC, 96(3), 2001, pp. 198-209

Authors: Demers, RY Tiwari, A Wei, J Weiss, LK Severson, RK Montie, J

Citation: Ry. Demers et al., Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality, CANCER, 92(9), 2001, pp. 2309-2317

Authors: Prescott, JL Montie, J Pugh, TW McHugh, T Veltri, RW

Citation: Jl. Prescott et al., Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens, CANCER, 91(11), 2001, pp. 2127-2135

Authors: Rubin, MA Bassily, N Sanda, M Montie, J Strawderman, MS Wojno, K

Citation: Ma. Rubin et al., Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma, AM J SURG P, 24(2), 2000, pp. 183-189

Authors: Crawford, ED Batuello, JT Snow, P Gamito, EJ McLeod, DG Partin, AW Stone, N Montie, J Stock, R Lynch, J Brandt, J

Citation: Ed. Crawford et al., The use of artificial intelligence technology to predict lymph node spreadin men with clinically localized prostate carcinoma, CANCER, 88(9), 2000, pp. 2105-2109

Authors: Raghavan, D Montie, J

Citation: D. Raghavan et J. Montie, Questions and responses, J UROL, 162(2), 1999, pp. 455-456